Savara Pharmaceuticals
SVRA
#6601
Rank
NZ$0.97 B
Marketcap
$5.67
Share price
-1.54%
Change (1 day)
-25.37%
Change (1 year)

Market capitalization of Savara Pharmaceuticals (SVRA)

Market cap: NZ$0.97 Billion

As of December 2024 Savara Pharmaceuticals has a market cap of NZ$0.97 Billion. This makes Savara Pharmaceuticals the world's 6601th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Savara Pharmaceuticals from 2001 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.97 B-3.31%
2023NZ$1.00 B261.27%
2022NZ$0.27 B34.69%
2021NZ$0.20 B139.56%
2020NZ$86.29 M-74.46%
2019NZ$0.33 B-14.82%
2018NZ$0.39 B-37.76%
2017NZ$0.63 B2034.93%
2016NZ$29.85 M-70.29%
2015NZ$0.10 B-11.84%
2014NZ$0.11 B97.2%
2013NZ$57.79 M80.29%
2012NZ$32.05 M60.23%
2011NZ$20 M-61.8%
2010NZ$52.37 M-47.04%
2009NZ$98.89 M747.86%
2008NZ$11.66 M-78%
2007NZ$53.02 M-83.94%
2006NZ$0.33 B2.5%
2005NZ$0.32 B281.48%
2004NZ$84.46 M50.25%
2003NZ$56.21 M331.15%
2002NZ$13.03 M-79.38%
2001NZ$63.23 M

End of Day market cap according to different sources

On Dec 23rd, 2024 the market cap of Savara Pharmaceuticals was reported to be:

NZ$0.98 Billion
by Nasdaq info icon info icon
NZ$0.98 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$37.02 M-96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.79 B 84.99%๐Ÿ‡บ๐Ÿ‡ธ USA